Educell

Cell therapy and tissue engineering in human medicine

Educell was founded in July 1997.

The company collaborates with academic, clinical and research institutions or enterprises to work on research projects and develop new technologies based on cell therapy.

Educell’s laboratory works in complians with standards for good laboratory and manufactering practice (GLP/GMP), current Good Tissue practice (cGTP) and relevant European regulation (23/2004/EC).

Nevenka Kregar Velikonja, Ph.D., Managing Director
Anja Tajhmajster, Administration Department
Nadja Polanc, Head of Cell Laboratory
Saša Puhar, Head of QC Laboratory

Letališka cesta 33
1000 Ljubljana
Slovenia
Phone: +386-1-547-1842
Fax: +386-1-547-1842

The technology for the treatment of damaged articular cartilage is directed by the autologous implantation of in vitro cultivated chondrocytes. Educell’s research focuses on four main programmes - including chondrocytes used in the treatment of arthrosis, for the treatment of vesicoureteral reflux, chondrocyte transplantation for the prevention of the narrowing of disc space in the spine and bone replacement for use in periodontology, orthopaedics and traumatology.

Educell’s first product, ChondroArt®, involves the isolation and cultivation of the patient’s healthy cartilage. Subsequenlty, a graft consisting of a suspension of chondrocytes/chondrocytes on collagen based scaffold is transplanted into the lesion and leads to complete regeneration of the joint. The product is currently further developed to allow less invasive treatments.